These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 2206782)
1. Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo. Müller TH; Su CA; Weisenberger H; Brickl R; Nehmiz G; Eisert WG Br J Clin Pharmacol; 1990 Aug; 30(2):179-86. PubMed ID: 2206782 [TBL] [Abstract][Full Text] [Related]
2. Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGI2 generation, and red cell deformability ex vivo in man. Saniabadi AR; Fisher TC; McLaren M; Belch JF; Forbes CD Cardiovasc Res; 1991 Mar; 25(3):177-83. PubMed ID: 2029709 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of thrombus formation by low-dose acetylsalicylic acid, dipyridamole, and their combination in a model of platelet-vessel wall interaction. Müller TH Neurology; 2001; 57(5 Suppl 2):S8-S11. PubMed ID: 11552048 [TBL] [Abstract][Full Text] [Related]
4. Enhanced antiplatelet effects of clopidogrel plus acetylsalicylic acid compared with acetylsalicylic acid alone or combined with extended-release dipyridamole in healthy volunteers. Caplain H Cerebrovasc Dis; 2005; 19(4):214-9. PubMed ID: 15703464 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of platelet aggregation in whole blood by dipyridamole and aspirin. Heptinstall S; Fox S; Crawford J; Hawkins M Thromb Res; 1986 Apr; 42(2):215-23. PubMed ID: 3715801 [TBL] [Abstract][Full Text] [Related]
6. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood). Violi F; Praticò D; Iuliano L; Balsano F J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906 [TBL] [Abstract][Full Text] [Related]
7. Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers. Cadroy Y; Thalamas C; Sakariassen K; Boneu B Thromb Res; 2005; 116(4):293-300. PubMed ID: 16038713 [TBL] [Abstract][Full Text] [Related]
8. [Effect on various platelet parameters of dipyridamole (225 mg/day) acetylsalicylic acid (150 mg/day) and their combination in healthy volunteers]. Aguilar Muñoz A; de la Cruz Cortés JP; Martos Crespo F; de Pablo Molina J; Sánchez de la Cuesta F Med Clin (Barc); 1985 Nov; 85(18):743-5. PubMed ID: 4094486 [No Abstract] [Full Text] [Related]
9. Interaction of platelets with subendothelium in humans treated with aspirin and dipyridamole alone or in combination. Escolar G; Bastida E; Ordinas A; Castillo R Thromb Res; 1985 Nov; 40(3):419-24. PubMed ID: 4082117 [No Abstract] [Full Text] [Related]
10. Effect of aspirin and dipyridamole on the interaction of human platelets with sub-endothelium: studies using citrated and native blood. Weiss HJ; Turitto VT; Vicic WJ; Baumgartner HR Thromb Haemost; 1981 Apr; 45(2):136-41. PubMed ID: 7256696 [TBL] [Abstract][Full Text] [Related]
11. Effects of dipyridamole and low-dose aspirin therapy on platelet adhesion to vascular subendothelium. Lauri D; Zanetti A; Dejana E; de Gaetano G Am J Cardiol; 1986 Dec; 58(13):1261-4. PubMed ID: 3788816 [TBL] [Abstract][Full Text] [Related]
12. Does the association dipyridamole-aspirin only act by a functional synergism? De la Cruz JP; Sanchez de la Cuesta F Gen Pharmacol; 1991; 22(2):271-4. PubMed ID: 2055420 [TBL] [Abstract][Full Text] [Related]
13. [The effect of low-dose acetylsalicylic acid on platelet aggregation parameters in vitro]. Cardona M; Escolar G; Roig E; Bastida E; Ordinas A; Sanz G Rev Esp Cardiol; 1992 Apr; 45(4):264-9. PubMed ID: 1598464 [TBL] [Abstract][Full Text] [Related]
14. [Effect of dipyridamole (225 mg/day) and acetylsalicylic acid (150 mg/day) on various platelet parameters in non-complicated diabetes mellitus]. Aguilar Muñoz A; de la Cruz Cortés JP; Martos Crespo F; García Arnés J; de Pablo Molina J; Sánchez de la Cuesta F Med Clin (Barc); 1986 May; 86(17):712-5. PubMed ID: 3736161 [No Abstract] [Full Text] [Related]
15. Magnitude and time course of platelet inhibition with extended release dipyridamole with or without aspirin in healthy Japanese volunteers. The AGgrenox versus Aspirin Therapy Evaluation (AGATE-Japan). Serebruany VL; Malinin AI; Hanley DF Thromb Haemost; 2008 Jan; 99(1):116-20. PubMed ID: 18217142 [TBL] [Abstract][Full Text] [Related]
17. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage? Serebruany VL; Malinin AI; Sane DC Am J Hematol; 2003 Apr; 72(4):280-1. PubMed ID: 12666142 [TBL] [Abstract][Full Text] [Related]
18. The interaction of varying doses of dipyridamole and acetyl salicylic acid on the inhibition of platelet functions and their effect on bleeding time. Rajah SM; Penny AF; Crow MJ; Pepper MD; Watson DA Br J Clin Pharmacol; 1979 Nov; 8(5):483-9. PubMed ID: 508556 [TBL] [Abstract][Full Text] [Related]
19. Cilostazol and dipyridamole synergistically inhibit human platelet aggregation. Liu Y; Cone J; Le SN; Fong M; Tao L; Shoaf SE; Bricmont P; Czerwiec FS; Kambayashi J; Yoshitake M; Sun B J Cardiovasc Pharmacol; 2004 Aug; 44(2):266-73. PubMed ID: 15243309 [TBL] [Abstract][Full Text] [Related]
20. Platelet deposition on human atherosclerotic lesions is decreased by low-dose aspirin in combination with dipyridamole. Sinzinger H; O'Grady J; Fitscha P J Int Med Res; 1988; 16(1):39-43. PubMed ID: 3350203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]